Search Clinical Pathways
Acute Asthma Exacerbation Clinical Pathway — PICU
The PICU Asthma Pathway provides guidance for the care of patients with severe asthma exacerbation requiring ICU care.
Atopic Dermatitis Clinical Pathway — All Settings
The suspected atopic dermatitis pathway highlights the care necessary in treating children with atopic dermatitis for all settings.
Pulmonary Hypertension Screening in Patients with Bronchopulmonary Dysplasia Clinical Pathway — ICU and Inpatient
Inpatient Clinical Pathway to standardize the process to screen for pulmonary hypertension in infants with Bronchopulmonary Dysplasia (BPD). BPD remains a major source of morbidity and mortality for extremely low birth weight infants.
COVID-19 Screening Clinical Pathway — Inpatient
Clinical Pathway for Inpatient Recommendations for SARS-CoV-2 Testing provides guidance for the evaluation and care of patients with suspected coronavirus (SARS-CoV-2).
Asthma, Known or New Diagnosis Clinical Pathway — Primary Care
This pathway should be used to guide the care of children ages 2-18 with known or suspected diagnosis of asthma.
Emergency Department and Inpatient Mitochondrial Clinical Pathway
This pathway guides the ED and inpatient care for patients of any age with Genetically confirmed, Primary (Definite) Mitochondrial Disease or Suspected Mitochondrial Disease.
Post-N/IICU Inpatient BPD Clinical Pathway
The post – N/IICU patient with severe Bronchopulmonary Dysplasia (BPD) clinical pathway will guide transfer from N/IICU to complex care service, weaning of respiratory support, and discharge planning.
Neuromuscular Compromise and Respiratory Failure Clinical Pathway — Inpatient and PICU
This pathway is intended for use in the inpatient pulmonary service and the PICU to guide care for patients with common neurodegenerative conditions affecting respiratory status.
Airway Clearance/Hyperinflation Therapy, Non-Pharmacological Clinical Pathway — ICU and Inpatient
This pathway will guide the respiratory therapist in modifying type and frequency of therapies based on clinical assessment in order to provide quality patient care.
Management of Infants with Lymphatic Disorders Clinical Pathway — Inpatient
This pathway is to be used for infants from birth to 1 year of age, admitted to an intensive care unit, with concern for lymphatic flow disorders without history of surgical/traumatic chylothorax, congenital heart disease, or isolated lymphatic mass.